Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Investing Activities: 2021-2024

Historic Cash from Investing Activities for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$3,000.

  • Biofrontera's Cash from Investing Activities was N/A to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4,000, marking a year-over-year change of. This contributed to the annual value of -$3,000 for FY2024, which is 100.48% down from last year.
  • Biofrontera's Cash from Investing Activities amounted to -$3,000 in FY2024, which was down 100.48% from $619,000 recorded in FY2023.
  • Biofrontera's Cash from Investing Activities' 5-year high stood at $619,000 during FY2023, with a 5-year trough of -$5.2 million in FY2022.
  • Its 3-year average for Cash from Investing Activities is -$1.5 million, with a median of -$3,000 in 2024.
  • In the last 5 years, Biofrontera's Cash from Investing Activities plummeted by 46,772.73% in 2022 and then surged by 112.01% in 2023.
  • Biofrontera's Cash from Investing Activities (Yearly) stood at -$11,000 in 2021, then slumped by 46,772.73% to -$5.2 million in 2022, then surged by 112.01% to $619,000 in 2023, then tumbled by 100.48% to -$3,000 in 2024.